A Data Collection Study for Patients With Adenocarcinoma Treated With the MyVaccx Immunotherapy Regimen.

NCT03695835 · clinicaltrials.gov ↗

COMPLETED

Status

27

Enrollment

INDIV

Sponsor class

Conditions

Adenocarcinoma

Interventions

DRUG: Immunotherapeutic Agents
DEVICE: Ablation

Sponsor

Gary Onik MD